Workshop on addressing ‘hidden hunger' begins at CSIR-CFTRI, Mysuru
The workshop's concept note, quoting the Global Burden of Disease 2021, states that the global prevalence of anaemia stands at 24.3%, with dietary iron deficiency being the leading cause. Anaemia accounts for approximately 52.1 million Disability-Adjusted Life Years (DALYs) globally, of which iron deficiency alone contributes around 34.5 million DALYs (60%). In India, dietary iron deficiency is responsible for an estimated 12 million DALYs, it added.
According to the National Family Health Survey (NFHS-5, 2019–21), 59% of women aged 15–49 years, and 67% of children aged 6–59 months in India are anaemic. Further, Comprehensive National Nutrition Survey (CNNS), 2016-18, data shows that 50-70% of anaemia cases are due to deficiencies of iron, folate (B9), and Vitamin B12, it stated.
The note also highlighted that Vitamin A and D deficiencies pose significant public health challenges. CNNS data indicate that 61% of children under the age of five are Vitamin A deficient, while 50% of children aged one to four years lack adequate Vitamin D.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hans India
17 hours ago
- Hans India
DMHO reviews performance of ASHA workers
Kurnool: A comprehensive ASHA review meeting was held at the Urban Primary Health Centre (UPHC) in Stantonpuram, Kurnool, on Tuesday. The meeting was graced by the District Medical and Health Officer (DMHO) Dr P Shantikala, who reviewed the performance of ASHA workers and emphasised key agenda items aligned with the ASHA Day initiatives. Dr Shantikala stressed the importance of timely data uploads on the ASHA app, including eligible couple services, distribution of iron and Vitamin A supplements, and neonatal care services. She also directed health workers to raise awareness about temporary family planning methods and ensure that the public is well-informed about free urban health services. Citizens visiting the OP section should be encouraged to bring their Aadhaar and phone numbers for proper documentation. Additionally, she instructed staff to expedite the NCD 3.0 survey on non-communicable diseases. Highlighting the Dengue Prevention Month (July 1–31), the DMHO called for awareness sessions at urban health centres and ward levels. She also emphasised the need for timely haemoglobin testing among pregnant women to detect anemia, followed by iron tablet distribution, iron sucrose injections, and, if necessary, referral to government hospitals for blood transfusions. The meeting was attended by DPMO Dr Uma, DPO Vijayaraju, biologist Venkateswarlu, Medical Officer Dr. Mounika, along with several health workers and ASHA facilitators.
Time of India
a day ago
- Time of India
Indians increasingly aware of weight loss drugs, but most wary their adoption: Survey
New Delhi: While the awareness of weight loss drugs in India is burgeoning at an unprecedented pace following the high-profile launches by global giants, most of the citizens in the country have reported to prefer non-medical options considering their side effects. According to a recent survey conducted by Morning Consult on behalf of the Physicians Committee for Responsible Medicine over 1000 individuals, 87 per cent of the respondents believe "it is important to learn about non-drug-supported weight loss methods following concerns over safety and long-term use." As per the survey findings, 82 per cent of respondents had heard of these drugs, however, only 18 per cent could correctly explain how these drugs work and 65 per cent voiced that their benefits are highly exaggerated. Commenting on the survey findings Dr Vanita Rahman, internal medicine physician with the Physicians Committee said that many people are concerned about side effects and safety and are asking what options exist beyond medications. As a better alternative, the medical experts suggest focusing on lifestyle changes such as a low fat based diet to sustain long term benefits. 'A plant-based diet—low in fat and rich in fiber—can support long-term weight control without the risks associated with drug therapies. It's a sustainable strategy that equips patients with safer, evidence-based options for weight control,' said Dr Rahman. Adding to it Dr Zeeshan Ali, a nutrition researcher with the Physicians Committee extended that a Plant-based diet reduces the risk of obesity among adults who are genetically predisposed to the disease, and can help people reach a healthier Body Mass Index (BMI). Citing a study which analyzed the findings of the last National Family Health Survey the committee noted that overweight and obesity tend to affect Indian families as a unit, not just individuals and should prioritize household-level interventions, over purely individual approaches. In March this year, US giant Eli Lilly launched its blockbuster drug Mounjaro (tirzepatide) in India while its arch-rival Danish drug maker Novo Nordisk followed suit with the launch of its alternative brand Wegovy (semaglutide) last month. According to PharmaTrack data, as of June 2025 Lilly has sold around 88,000 identical units of Mounjaro (including both 2.5 mg and 5mg vial) while Novo has sold close to 17,000 units since its launch in June this year. Of India's total ₹628 crore anti-obesity drug market, semaglutide accounts for 66 per cent of the total market with a moving annual turnover (MAT) of ₹412 crore while tirzepatide with a MAT of ₹50 crore owns 8 per cent of the total share.
Time of India
2 days ago
- Time of India
IIT Delhi announces 6-month online executive programme focused on AI in Healthcare: Check details here
The Indian Institute of Technology (IIT) Delhi, in partnership with TeamLease EdTech, has introduced a comprehensive online executive programme in Artificial Intelligence (AI) in Healthcare, specially designed for working professionals across diverse domains. Scheduled to begin on November 1, 2025, this programme seeks to bridge the gap between healthcare and technology by imparting industry-relevant AI skills to professionals, including doctors, engineers, data scientists, and med-tech entrepreneurs. Applications for the programme are currently open and will remain so until July 31, 2025. Interested professionals are encouraged to submit their applications through the official IIT Delhi CEP portal. This initiative is a part of IIT Delhi 's eVIDYA platform, developed under the Continuing Education Programme (CEP), and aims to foster applied learning through a blend of theoretical instruction and hands-on experience using real clinical datasets. This course offers a unique opportunity to upskill with one of India's premier institutes and contribute meaningfully to the rapidly evolving field of AI-powered healthcare. Programme overview To help prospective applicants plan better, here is a quick summary of the programme's key details: Category Details Course duration November 1, 2025 – May 2, 2026 Class schedule Online and conducted over weekends Programme fee ₹1,20,000 + 18% GST (Payable in two easy installments) Application deadline July 31, 2025 Learning platform IIT Delhi Continuing Education Programme (CEP) portal Who can benefit from this course? The programme is tailored for a wide spectrum of professionals who are either involved in healthcare or aspire to work at the intersection of health and technology. You are an ideal candidate if you are: • A healthcare practitioner or clinician with limited or no background in coding or artificial intelligence, but curious to explore AI's applications in medicine. • An engineer, data analyst, or academic researcher engaged in health-tech innovations or biomedical computing. • A med-tech entrepreneur or healthcare startup founder looking to incorporate AI-driven solutions into your business or products. Curriculum overview Participants will engage with a carefully curated curriculum that balances core concepts with real-world applications. Key modules include: • Introduction to AI, Machine Learning (ML), and Deep Learning (DL) concepts. • How AI is used to predict disease outcomes and assist in clinical decision-making. • Leveraging AI in population health management and epidemiology. • Application of AI for hospital automation and familiarity with global healthcare data standards like FHIR and DICOM. • Over 10 detailed case studies showcasing successful AI applications in hospitals and clinics. • A hands-on project with expert mentorship from faculty at IIT Delhi and clinicians from AIIMS, enabling learners to apply their knowledge to real clinical challenges. Learning outcomes you can expect By the end of this programme, participants will be equipped with the ability to: • Leverage AI technologies to enhance clinical workflows, automate processes, and support evidence-based decision making in healthcare. • Work effectively with diverse data sources such as Electronic Medical Records (EMRs), radiology images, genomics data, and Internet of Things (IoT)-based health devices. • Develop and deploy functional AI models tailored for practical use in hospitals, diagnostics, and public health infrastructure. • Earn a prestigious certification from IIT Delhi, enhancing your professional credentials in the health-tech domain. Ready to navigate global policies? Secure your overseas future. Get expert guidance now!
